A Win For Psyence Biomedical Ltd.

Mon, Aug 04, 2025 at 07:01 PM

Psyence Biomedical Ltd. (PBM:NASDAQ) jumped higher at $4.54, a gain of 92.4%. The stock appeared on our News Catalysts scanner on Mon, Aug 04, 2025 at 11:38 AM in the 'INVESTOR UPDATE' category. From Mon, Jul 21, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days

About Psyence Biomedical Ltd. (PBM:NASDAQ)

Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.

Top 10 Gainers:

Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
Verb Technology Company, Inc. (VERB:NASDAQ), 114.27%
Psyence Biomedical Ltd. (PBM:NASDAQ), 92.37%
CommScope Holding Company, Inc. (COMM:NASDAQ), 86.26%
BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 85.4%
Steelcase Inc. (SCS:NYSE), 62.87%
Earlyworks Co., Ltd (ELWS:NASDAQ), 52.56%
CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 51.16%
Lichen International Limited (LICN:NASDAQ), 48.03%
ATA Creativity Global (AACG:NASDAQ), 36.11%